Editas Medicine
EDIT
EDIT
234 hedge funds and large institutions have $384M invested in Editas Medicine in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 69 increasing their positions, 60 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less capital invested
Capital invested by funds: $465M → $384M (-$80.9M)
30% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 43
Holders
234
Holding in Top 10
–
Calls
$5.68M
Puts
$4.54M
Top Buyers
| 1 | +$5.86M | |
| 2 | +$5.82M | |
| 3 | +$4.12M | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.04M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.39M |
Top Sellers
| 1 | -$9.76M | |
| 2 | -$7.67M | |
| 3 | -$6.22M | |
| 4 |
Man Group
London,
United Kingdom
|
-$3.63M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.09M |